Uptravi 1,600 MCG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQWN8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,594
Award facts
- Contract value 100% obligated
- $51,594.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $51,594.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of UPTRAVI 1,600 micrograms. The delivery order, issued without set-aside designation, is scheduled for completion by February 26, 2026, and represents a single-award transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
This delivery order falls under the larger PPV-G GEN V acquisition strategy, a $30.3 billion government-wide pharmaceutical supply program designed to provide Department of Defense healthcare facilities with comprehensive pharmaceutical products and medical consumables. DMS Pharmaceutical Group holds a prime vendor contract under this initiative with a $499,999,999 ceiling value extending through December 31, 2036, positioning the company as a critical supplier for military medical operations. The company's established track record of performance across diverse pharmaceutical categories, including specialty pharmaceuticals, biologics, and routine medications, supports its role as a regional prime vendor contractor with no identified subcontractors on this award.
Quick answers
Who was awarded contract SPE2DR26FQWN8?
SPE2DR26FQWN8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FQWN8 worth?
The government has obligated $51,594 on SPE2DR26FQWN8.
Is contract SPE2DR26FQWN8 an order under another contract?
Yes. SPE2DR26FQWN8 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWN8 competed?
The extent of competition for SPE2DR26FQWN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award